Diversified Healthcare Trust Stock: price and insider trades · United States · SEC (Form 4)

About Diversified Healthcare Trust

Diversified Healthcare Trust (NYSE/NASDAQ, United States) is a Maryland-organized real estate investment trust focused on healthcare-related real estate. Founded in 1998, the company has built a portfolio anchored in senior living communities, medical office assets, life science properties, and other healthcare-oriented real estate. Its principal executive offices are in Newton, Massachusetts, and its footprint is almost entirely U.S.-based, making it a straightforward domestic healthcare real estate exposure for investors seeking income-oriented real assets linked to demographic demand. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1075415/000110465926032079/tm263087d2_ars.pdf)) DHC’s business model centers on owning and leasing properties that serve the healthcare value chain. As of December 31, 2025, the portfolio included 298 properties across 33 states and Washington, D.C., comprising 221 senior living communities, 67 medical office and life science properties, and 10 wellness centers. The company also held interests in two unconsolidated joint ventures that own additional medical office and life science assets, providing further diversification across property type and tenancy. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1075415/000110465926032079/tm263087d2_ars.pdf)) From a competitive standpoint, Diversified Healthcare Trust sits in a niche between broad-based healthcare REITs and more specialized senior housing landlords. Its appeal lies in exposure to secular U.S. healthcare demand: aging demographics, longer life expectancy, and ongoing demand for outpatient, senior housing, and research-oriented space. Management explicitly frames the healthcare property market as one of the more resilient commercial real estate sectors in the United States, supported by structural demand growth rather than short-term economic cycles. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1075415/000110465926032079/tm263087d2_ars.pdf)) The company’s revenue base is driven by rents and related cash flows from senior housing, medical office, and life science tenants. Its strategy emphasizes geographic diversification and a mix of care delivery, medical practice, and scientific research uses, which can help reduce concentration risk relative to conventional office real estate. For investors, that means DHC is less a pure operating healthcare company and more an asset-backed property owner whose earnings are tied to occupancy, leasing performance, and operator quality. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1075415/000110465926032079/tm263087d2_ars.pdf)) Recent developments have been important. In September 2025, DHC announced agreements tied to the sale by AlerisLife of 116 management agreements for DHC SHOP communities operated by Five Star Senior Living, with transitions expected to complete by year-end. DHC said it expected to receive estimated net proceeds of $25 million to $40 million from the sale of AlerisLife’s assets, based on its 34% ownership stake, and intends to use proceeds to reduce leverage and reinvest in its SHOP segment. Separately, a December 2025 Form 4 showed CEO Christopher J. Bilotto buying common shares, a disclosure that may be read as a management confidence signal, though investors should treat insider transactions as one data point rather than a standalone thesis. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1075415/000110465925086699/tm2525088d1_ex99-2.htm))